Yani Arhab | Viral Strategies | Best Researcher Award

Posted on 20/11/202421/11/2024 by PencisLeave a Comment

Dr. Yani Arhab | Viral Strategies | Best Researcher Award

SUNY Downstate Health Sciences University | United States

Author Profile

Scopus

Orcid ID

Google Scholar

YANI ARHAB, PHD 🎓🔬

EARLY ACADEMIC PURSUITS 📚

Yani Arhab’s academic journey began at the University François Rabelais of Tours (France), where he earned his BSc in Biology. During his studies, he participated in an Erasmus program, studying at Queen Mary University of London. He continued his education at University Claude Bernard Lyon1, completing his Master's in Structural & Functional Biochemistry. Yani further honed his skills during a Master’s 2 training at the ICBMS, where he worked on the structural and functional characterization of phospholipases D in plants.

PROFESSIONAL ENDEAVORS 💼

Yani's career spans multiple prestigious institutions and roles. From 2015 to 2018, he earned his PhD at the University of Lyon, where he focused on phospholipases D, under the guidance of Pr. A. Abousalham and Dr. A. Noiriel. Following this, he served as a full-time associate professor at Université Claude Bernard Lyon1 in 2018-2019. Since 2019, Yani has been a Postdoctoral Associate at the State University of New York, Downstate Medical Center, where he is studying the reconstitution of ribosomal initiation complexes on viral RNA Internal Ribosome Entry Sites (IRES) under the mentorship of Dr. Christopher Hellen and Dr. Tatyana Pestova.

CONTRIBUTIONS AND RESEARCH FOCUS ON VIRAL STRATEGIES🧬

Yani’s research focuses on biochemistry, particularly in the areas of ribosomal initiation, lipid biochemistry, and the structural and functional analysis of enzymes. His work on phospholipases D has contributed significantly to understanding lipid metabolism and its impact on cellular functions. In his current research, he is studying viral RNA IRES and their mechanisms in translation initiation, which has important implications for viral infections and potential therapeutic targets.

IMPACT AND INFLUENCE 🌍

Yani’s work is influencing multiple fields of molecular biology and biochemistry, particularly through his contributions to understanding the molecular mechanisms behind viral translation and enzyme function. His research on IRES mechanisms is helping expand our knowledge of viral RNA translation, with the potential to influence future antiviral strategies.

ACADEMIC CITATIONS 📈

Throughout his academic career, Yani Arhab has gained recognition for his innovative research, presenting his findings at international conferences such as the Translational Control Symposium at Cold Spring Harbor Laboratory and the Ribosome Structure & Function Conference. His research contributions have resulted in numerous publications and are frequently cited by peers in the fields of biochemistry, molecular biology, and virology.

LEGACY AND FUTURE CONTRIBUTIONS 🔮

Yani Arhab’s legacy is defined by his commitment to advancing our understanding of molecular biology. He has built a solid foundation of research that will continue to shape the future of biochemical research, particularly in the fields of RNA biology and viral research. Looking ahead, he plans to further investigate the complex interactions of ribosomal initiation and their implications for therapeutic development, particularly for viral diseases.

AWARDS AND SCHOLARSHIPS 🏆

2015, 2016, 2018: Research funds from the Ligue National Contre le Cancer (€15,000)
2017: FEBS+3 travel grant (€750)
2015: Ph.D. bursary recipient

PROFESSIONAL MEMBERSHIPS 🤝

Member of the AFC (French Crystallography Society)
Member of the SFBBM (French Molecular Biology and Biochemistry Society)
Associate Professor in Biochemistry and Molecular Biology since 2019

TEACHING EXPERIENCE 🍎

Yani Arhab has contributed to the education of future scientists by teaching both lectures and experimental courses in biochemistry. He has mentored undergraduate students in subjects such as protein purification, lipid characterization, and enzymatic assays, fostering the next generation of researchers. Yani Arhab's work exemplifies the intersection of molecular research and practical application in medicine, showcasing his contributions to both academia and the scientific community at large.

NOTABLE PUBLICATIONS 📑

"Heterologous expression, kinetic characterization and molecular modeling of a new sn-1,3-regioselective triacylglycerol lipase from Serratia sp. W3"

Authors: Eddehech, A. , Rahier, R. , Smichi, N. , Sayari, A. , Zarai, Z.
Journal: Process Biochemistry
Year: 2021

"Phospholipase D inhibitors screening: Probing and evaluation of ancient and novel molecules"

Authors: Arhab, Y. , Bessaa, K. , Abla, H. , Abousalham, A. , Noiriel, A
Journal: International Journal of Biological Macromolecules
Year: 2021

"Corrigendum to “Production, purification and functional characterization of phospholipase C from Bacillus thuringiensis with high catalytic activity”

Authors: Eddehech, A. , Smichi, N. , Arhab, Y. , Gargouri, Y. , Zarai, Z.
Journal: Process Biochemistry
Year: 2019

"Production, purification and functional characterization of phospholipase C from Bacillus thuringiensis with high catalytic activity"

Authors: Eddehech, A. , Smichi, N. , Arhab, Y. , Gargouri, Y. , Zarai, Z.
Journal: Process Biochemistry
Year: 2019

"Plant phospholipase D mining unravels new conserved residues important for catalytic activity"

Authors: Arhab, Y. , Abousalham, A. , Noiriel, A.
Journal: Molecular and Cell Biology of Lipids
Year: 2019

Peiping Xu | Medical Science | Best Researcher Award

Posted on 26/10/202426/10/2024 by PencisLeave a Comment

Dr. Peiping Xu | Medical Science | Best Researcher Award

Guangzhou University of Chinese Medicine | China

Author Profile

Scopus

Xu Peiping: Pioneering Research Fellow in Traditional Chinese Medicine 🌿🧬

EARLY ACADEMIC PURSUITS 🎓

Xu Peiping’s academic journey laid a solid foundation for a career dedicated to groundbreaking research in antiviral pharmacology and the field of traditional Chinese medicine (TCM). Xu pursued rigorous studies in pharmacology and related fields, gaining expertise that would later inform innovative approaches to studying TCM's molecular mechanisms. This strong academic background has been instrumental in shaping Xu’s approach to leveraging modern technologies like bioinformatics and artificial intelligence to explore TCM's antiviral potential.

PROFESSIONAL ENDEAVORS AND APPOINTMENTS 🏛️

Currently a Research Fellow at the Institute of Tropical Medicine, Guangzhou University of Chinese Medicine, Xu Peiping has made significant contributions to advancing the scientific understanding of TCM. Xu’s role at this prestigious institution involves leading projects that investigate TCM's antiviral and immune-modulatory effects. This research aims to bridge the gap between traditional and modern medicine, using cutting-edge technologies to expand the application of TCM in contemporary medical science. Xu is a sought-after expert in interdisciplinary research and is known for fostering collaborations across both national and international platforms to promote TCM research.

CONTRIBUTIONS AND RESEARCH FOCUS ON MEDICAL SCIENCE 🔬

Xu’s research focuses on the molecular mechanisms underlying antiviral effects and inflammatory immune pharmacology within TCM. By applying technologies such as computer-aided drug design, network pharmacology, systems pharmacology, bioinformatics, and AI, Xu’s work uncovers how TCM formulations interact with viral mechanisms and immune responses at a molecular level. This approach provides a scientific basis for TCM's efficacy, opening the door to more targeted antiviral therapies and innovative pharmaceutical applications.

IMPACT AND INFLUENCE 🌏

Xu Peiping's research has not only contributed to scientific knowledge but has also driven significant advancements in public health. The work on TCM’s antiviral and immune-modulatory properties has garnered considerable attention within the medical community and among policymakers who see TCM as an important resource in global health. Xu’s findings are particularly impactful in regions where TCM is integrated into healthcare systems, and his research has influenced policy discussions about TCM's role in preventive and curative healthcare strategies.

ACADEMIC CITES AND RECOGNITION 🏅

Xu’s work is widely cited in leading pharmacological and medical journals, reflecting a respected position within the academic community. Through numerous peer-reviewed publications, Xu’s research has contributed significantly to understanding TCM's pharmacology, reinforcing the academic credibility of traditional remedies. Xu has also been recognized with awards that highlight contributions to pharmacology, demonstrating his expertise and commitment to both scientific innovation and the future of TCM.

LEGACY AND FUTURE CONTRIBUTIONS 🌟

Xu Peiping’s legacy in the field of TCM is one of bridging traditional and modern science to address pressing health challenges. His pioneering research is shaping a future where integrative medicine, powered by modern technologies, enhances our understanding and utilization of traditional treatments. Xu’s ongoing work in TCM-based antiviral and immunological research continues to inspire new generations of researchers to explore the intersection of technology and traditional medicine, ensuring that his contributions will have a lasting impact on both the field of pharmacology and public health.

NOTABLE PUBLICATIONS 📑

"Identification and Analysis of Biomarkers Associated with Lipophagy and Therapeutic Agents for COVID-19"

Authors: Wu, Y. , Wu, Z. , Jin, Q. , Liu, J. , Xu, P.
Journal: Viruses
Year: 2024

"Identification of mitochondria-related biomarkers in influenza viral pneumonia and potential mechanism of Yinqiao Anti-infective Powder"

Authors: Wu, Z. , Wu, Y. , Zhang, Y. , Liu, J. , Xu, P.
Journal: Chinese Traditional and Herbal Drugs
Year: 2024

"Analysis and identification of potential type II helper T cell (Th2)-Related key genes and therapeutic agents for COVID-19"

Authors: Jin, Q. , Li, W. , Yu, W. , Liu, J. , Xu, P.
Journal: Computers in Biology and Medicine
Year: 2022

"Geraniin as a potential inhibitor of SARS-CoV-2 3CLpro"

Authors: Yu, W.-D. , Jin, Q.-Y. , Zeng, M.-S. , Liu, J.-Y. , Xu, P.-P
Journal: Natural Product Research
Year: 2022

"Effect of paeoniflorin on acute lung injury induced by influenza A virus in mice. Evidences of its mechanism of action"

Authors: Yu, W. , Zeng, M. , Xu, P. , Liu, J. , Wang, H.
Journal: Phytomedicine
Year: 2021

Sang Yeon Cho | Molecular Cancer Biology | Best Researcher Award

Posted on 26/09/202430/09/2024 by PencisLeave a Comment

Dr. Sang Yeon Cho | Molecular Cancer Biology | Best Researcher Award

Chungna National University | South Korea

Author Profile

Scopus

Google Scholar

BIOGRAPHY OF SANG YEON CHO 🌟

EARLY ACADEMIC PURSUITS 🎓

Sang Yeon Cho embarked on his academic journey at Chungnam National University, where he earned his Bachelor's degree in Biochemistry in 2012. He further pursued an M.S. in Medicine, obtaining his MD degree in 2021. Currently, he is completing his Ph.D. in New Drug Discovery and Development, expected to graduate in February 2025. His strong foundation in the sciences has equipped him with the skills necessary for innovative research in the medical field.

PROFESSIONAL ENDEAVORS 🏥

Currently, Dr. Cho serves as the Vice Director of the Metro Neurosurgery Clinic in Daejeon, South Korea, since October 2022. Prior to this role, he was the Vice Director of Hurisarang Hospital from March 2021 to September 2022. His leadership positions reflect his commitment to advancing medical practice and enhancing patient care.

CONTRIBUTIONS AND RESEARCH FOCUS ON MOLECULAR CANCER BIOLOGY 🔬

As the Director of ChoLab since 2018, Dr. Cho has focused on cancer genomics and new drug discovery. His research has investigated the molecular mechanisms underlying cancer, emphasizing drug resistance and therapeutic targets. He has actively contributed to several labs, including the Neuroglia Lab and the Nano Primo Research Center, showcasing his multidisciplinary approach to tackling complex medical challenges.

IMPACT AND INFLUENCE 🌍

Dr. Cho's work has significantly influenced the field of medical genetics and cancer research. His publications in high-impact journals highlight the clinical significance of his findings, making substantial contributions to understanding cancer prognosis and treatment. Through his research, he aims to bridge the gap between laboratory discoveries and clinical applications, improving patient outcomes.

ACADEMIC CITATIONS 📚

His research output includes numerous peer-reviewed articles in respected journals such as BMC Medical Genomics, Scientific Reports, and BMC Cancer, where he explores topics like drug resistance, immunotherapy biomarkers, and cancer prognosis. His findings have garnered attention and citations within the academic community, underscoring the relevance and quality of his work.

LEGACY 🏆

Dr. Cho's dedication to advancing cancer research and patient care has already left a mark on the field. His innovative approach, exemplified by multiple patents related to AI in healthcare and cancer diagnostics, positions him as a forward-thinking researcher poised to shape future developments in medical science.

FUTURE CONTRIBUTIONS 🔮

Looking ahead, Dr. Cho aims to continue his research in cancer treatment and drug discovery, integrating cutting-edge technologies like artificial intelligence to enhance therapeutic strategies. With his expected Ph.D. completion in 2025, he is set to further expand his contributions to the field and inspire the next generation of medical researchers.

NOTABLE PUBLICATIONS 📑

"A method for the observation of the primo vascular system in the thoracic duct of a rat"

Authors: Kim, S., Jung, S.J., Cho, S.Y., Soh, K.-S., Kim, S.
Journal: Evidence-based Complementary and Alternative Medicine
Year: 2013

"Protocol for the Observation of the Primo Vascular System in the Lymph Vessels of Rabbits"

Authors: Jung, S.J., Cho, S.Y., Bae, K.-H., ... Song, Y.-K., Soh, K.-S.
Journal: Journal of Acupuncture and Meridian Studies
Year: 2012

Jer-Yen Yang | Metabolic Disorders and their Genetic | Excellence in Research

Posted on 17/02/202417/02/2024 by PencisLeave a Comment

Prof Dr. Jer-Yen Yang | Metabolic Disorders and their Genetic | Excellence in Research

China Medical University | Taiwan

Author Profile

Scopus

Orcid ID

Google Scholar

EARLY ACADEMIC PURSUITS

Jer-Yen Yang began his academic journey with a Bachelor of Science degree in Plant Pathology from National Chung-Hsing University, Taiwan, followed by a Master of Science in Biotechnology from National Taiwan Ocean University. During this time, his research focused on the transfer and expression of exogenous genes in zebrafish, under the mentorship of Dr. Jen-Lieh Wu. Yang furthered his education by pursuing a Ph.D. in Cancer Biology and Pharmacology at the University of Texas MD Anderson Cancer Center, under the guidance of Dr. Mien-Chie Hung. His doctoral research delved into targeting forkhead transcription factors in cancer therapy.

PROFESSIONAL ENDEAVORS

Yang's postdoctoral training expanded his expertise in cancer research. He first served as a Postdoctoral Fellow at the University of Texas MD Anderson Cancer Center, investigating EGFR signaling in cancer malignancy under the mentorship of Dr. Mien-Chie Hung. Subsequently, he joined Stanford University's School of Medicine as a Postdoctoral Fellow, focusing on the Hedgehog pathway and cancer metabolism in brain tumors under the guidance of Dr. Matthew P. Scott.

CONTRIBUTIONS AND RESEARCH FOCUS ON METABOLIC DISORDERS AND THEIR GENETIC

Throughout his academic and professional career, Yang has made significant contributions to the field of cancer and developmental biology. His research interests encompass various aspects of cancer biology, including signaling pathways, tumor metabolism, and therapeutic targets. He has particularly explored the roles of forkhead transcription factors, EGFR signaling, and the Hedgehog pathway in cancer progression and therapy.

IMPACT AND INFLUENCE

Yang's work has had a profound impact on cancer research, shaping our understanding of molecular mechanisms underlying tumor development and progression. His insights into signaling pathways and therapeutic targets have the potential to advance cancer treatment strategies, ultimately benefiting patients worldwide.

ACADEMIC CITATIONS

Yang's research contributions have been recognized by his peers, as evidenced by his numerous invited presentations at prestigious institutions and conferences worldwide. Additionally, his publications have garnered significant attention within the scientific community, as reflected by his citation metrics and academic awards.

LEGACY AND FUTURE CONTRIBUTIONS

As an Associate Professor at the Graduate Institute of Biomedical Sciences, China Medical University, Yang continues to pursue innovative research aimed at unraveling the complexities of cancer biology. His interdisciplinary approach and collaborative efforts hold promise for further advancements in cancer therapy and biomedical sciences, ensuring a lasting legacy of impactful contributions to the field.

Notable Publications

Heat Shock Factor 1 Inhibition: A Novel Anti-Cancer Strategy with Promise for Precision Oncology 2023(1)

PRMT1 is an important factor for medulloblastoma cell proliferation and survival 2022(3)

Hedgehog pathway inhibitors against tumor microenvironment 2021(22)

Activation of AMPK sensitizes medulloblastoma to Vismodegib and overcomes Vismodegib-resistance 2021(6)